800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
Sponsored| Name | Address | City |
|---|---|---|
| Metro Treatment of Maryland, LP | 2053 Day Road | Hagerstown |
| Phoenix Health Center | 217 East Antietam Street | Hagerstown |
| New Season Treatment Center | Hagerstown | 16110 Everly Rd Suite #2 | Hagerstown |
| Martinsburg Institute – Methadone Clinic & Suboxone Clinic | 223 Eagle School Road | Martinsburg |
| Genesis Treatment Services | 1106 Business Pkwy S # B | Westminster |
| Concerted Care Group Frederick | 300 B Scholls Lane | Frederick |
| Genesis Treatment Services | 1160 W Patrick Street | Frederick |
| BH Health Services Inc | 450 E. Main Street | Westminster |
| Frederick Institute | 5716-C Industry Lane | Frederick |
No results found!
Opioid use disorder treatment in Hagerstown and Washington County
Hagerstown is the seat of Washington County and the largest city in the Maryland Panhandle, and its treatment options reflect that regional role. Because the city sits near the Pennsylvania and West Virginia lines, its opioid treatment programs and office-based prescribers serve people from across the tri-state area, not just Washington County. For someone with opioid use disorder (OUD), that means more than one type of care is usually within reach: methadone through a licensed clinic, or buprenorphine and naltrexone through a clinic or a doctor’s office. The listings on this page show providers you can contact directly. If you are not sure where to start, the helpline can talk through the options with you.
Your medication and setting options
Three medications are approved to treat opioid use disorder, and they are offered in two kinds of settings. Understanding the difference tells you what the listings above actually represent.
Methadone for OUD is provided only through a licensed opioid treatment program (OTP), not a regular pharmacy. You visit the program for dosing, often daily at first. Buprenorphine, including Suboxone and other buprenorphine-naloxone products, can be prescribed in a doctor’s office and filled at a pharmacy, or provided through a clinic; longer-acting options such as the monthly injection Sublocade are also available. Naltrexone, including the monthly Vivitrol injection, can be prescribed by any licensed provider, but it is started only after a person has stopped using opioids for a set time. A program that runs as an OTP can dispense methadone on site; office-based opioid treatment (OBOT) means a clinician prescribes buprenorphine or naltrexone that you fill at a pharmacy. Many people do well on any of the three, so the choice is one to make with a clinician rather than something to settle before you call. If it helps to see the trade-offs first, this overview of how methadone and Suboxone compare lays them out, and this explainer covers what to expect from methadone specifically.
Starting treatment: what the first visit looks like
The first step is an intake assessment, where a provider reviews your history and, if appropriate, begins medication the same day. Some Hagerstown-area programs offer same-day or walk-in intake; the listings and the helpline can help you find one. Bring a photo ID and any treatment records you have, though missing paperwork should not stop you from being seen. If you have been using fentanyl, timing matters for buprenorphine: starting it too soon after your last use can trigger sudden, severe withdrawal (called precipitated withdrawal), so a clinician plans the first dose with you. This is a routine part of care and a good question to ask when you call. You can read more about treatment when fentanyl is involved and about getting started with opioid use disorder treatment.
Take-home doses, telehealth, and current rules
Federal rules updated in 2024 expanded take-home methadone (up to a 28-day supply for patients who are stable in treatment) and allowed treatment to start by telehealth, with take-home eligibility decided by the program based on your progress. For buprenorphine, telehealth flexibilities remain in place as of July 2026: it can often be started through a telehealth visit, including by phone in many cases, without a prior in-person visit. Those telehealth rules run through the end of 2026 and are still being finalized, so confirm what is current with a provider. Methadone for OUD is still started and dispensed through an opioid treatment program, though some programs can begin care with a telehealth visit. If you are transferring from another clinic or returning after a break, ask a program directly about guest dosing and how they handle continuity, and know that staying at a steady dose is part of what makes long-term treatment work.
Paying for care in Maryland
Maryland’s Medicaid program, HealthChoice, covers all three medications for opioid use disorder across both opioid treatment programs and office-based settings, administered through the state’s managed care organizations and the Maryland Medicaid Pharmacy Program. Coverage of buprenorphine and naltrexone can carry conditions such as documented counseling, so it is worth confirming details with the plan or provider. Private insurance and Medicare also cover MOUD, and many programs offer self-pay or sliding-scale options. Cost is often the first worry, so ask each provider what they accept before your first visit; the listings note this where the data is available.
The overdose picture here, and why treatment matters
The trend in Washington County has been moving in the right direction. The Washington County Health Department reported that local fatal overdoses fell nearly 22 percent over a one-year period (November 2022 to November 2023), drawing on data from the Maryland Overdose Data Dashboard and the Office of the Chief Medical Examiner. Statewide, the improvement has continued: the Maryland Department of Health recorded 1,315 fatal overdoses in 2025, the lowest in a decade and down 53 percent from the 2021 peak of 2,800. Fentanyl still drives most opioid deaths in Maryland, which is why fast access to medication and to naloxone matters. These numbers reflect real people and real loss, and they also show that treatment and prevention are working. If you are weighing whether to start, that is the encouraging part: effective care is available locally, and the next step can be a single phone call. For background, here is an overview of opioid use disorder and how it is treated.
A local path from crisis to ongoing treatment
One thing that sets the Hagerstown area apart is a direct bridge from an overdose crisis into medication treatment. Using nearly $465,000 in SAMHSA grant funding, the Washington County Health Department partnered with Meritus Medical Center to add crisis stabilization beds, where a person can stay up to 48 hours, begin medication for opioid use disorder, and get a warm handoff to peer support and longer-term outpatient care. For a family member helping someone after an overdose, or for anyone who feels ready only in a narrow window, that kind of immediate, low-barrier entry point can make the difference. The county has also expanded community naloxone access, including through vending machines that offer free supplies.
Pregnancy, reentry, and other specific situations
Some situations call for extra planning. For pregnant patients, methadone and buprenorphine are the recommended standard of care before, during, and after pregnancy, and Maryland’s MOM Program provides enhanced case management for pregnant and postpartum Medicaid participants with OUD through the state’s managed care organizations, supported by the University of Maryland’s MACS for MOMs clinician consultation service. Seeking treatment is the protective choice, and providers experienced in perinatal care can help you plan for a healthy pregnancy. For people leaving incarceration, Maryland’s HealthChoice reentry initiative (approved by federal regulators in January 2025 and implemented starting July 1, 2025) lets Medicaid cover MOUD and related services up to 90 days before release, which supports continuity into the community, the period when the risk of overdose is highest. Substance use treatment records also carry strong federal confidentiality protections under 42 CFR Part 2; ask any program about its policies if privacy is a concern. Families supporting someone can start with this guide to helping a loved one into treatment, and pregnant patients can read more about methadone and pregnancy.
Naloxone and overdose safety
Naloxone, the medication that reverses an opioid overdose, is widely available in Maryland. Under a statewide standing order from the Maryland Department of Health (most recently updated in August 2025), any Maryland-licensed pharmacist can dispense any formulation, including over-the-counter Narcan, to anyone, with no personal prescription and no required training. Free naloxone is also distributed through community organizations funded by the Maryland Overdose Response Program. Maryland’s Good Samaritan Law protects people who call 911 during an overdose from arrest or prosecution for certain drug-related offenses, so calling for help is always the right move. Keeping naloxone on hand is a sensible precaution for anyone in or near treatment, and a return to use is a manageable part of recovery for many people, not a failure. Learn the signs and response steps in this guide to recognizing and responding to an overdose.
Common questions about treatment in Hagerstown
Do I have to go to a clinic every day?
At first, methadone usually means daily visits to an opioid treatment program. As you stabilize, federal rules updated in 2024 allow take-home supplies of up to 28 days for patients who are stable, at the program’s discretion. Buprenorphine and naltrexone, prescribed in an office and filled at a pharmacy, do not require daily visits.
Can I get same-day treatment?
Sometimes, yes. Some Hagerstown-area programs offer same-day or walk-in intake and can begin medication the same day when it is appropriate. Availability varies, so call the providers in the listings or the helpline to find current openings.
What is the difference between methadone and Suboxone?
Both reduce cravings and withdrawal. Methadone for OUD is dispensed only through a licensed clinic; Suboxone (a buprenorphine-naloxone medication) can be prescribed in a doctor’s office and filled at a pharmacy. Which fits you depends on your history and preferences, a decision to make with a clinician. You can compare the two medications here.
Will my insurance cover it?
Maryland’s HealthChoice Medicaid program covers all three medications in both clinic and office settings, and private insurance and Medicare cover MOUD as well. Some coverage carries conditions such as documented counseling. Confirm specifics with the plan or provider before you start.
Is it safe to be on medication long term?
Yes. Major health authorities, including SAMHSA and NIDA, describe long-term medication as legitimate, effective treatment for a chronic condition, not a crutch or an unfinished step. Some people take medication for years; some taper later. That timing is a clinical decision. Read about how and when treatment can end.
Last reviewed and disclosures
Last reviewed July 2026.
Sources:
- SAMHSA, Medications for Opioid Use Disorder overview and 42 CFR Part 8 final rule (2024).
- DEA and HHS, Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities (effective January 1 to December 31, 2026) and Expansion of Buprenorphine Treatment via Telemedicine Encounter final rule (effective December 31, 2025).
- Maryland Department of Health, Behavioral Health Administration, Overdose Data (2025 statewide figure).
- Washington County Health Department, county fatal overdose figures and crisis stabilization partnership with Meritus Medical Center.
- Maryland Department of Health, statewide naloxone standing order (updated August 2025) and Maryland Overdose Response Program.
- Centers for Medicare and Medicaid Services, approval of Maryland HealthChoice 1115 Reentry Demonstration (January 13, 2025).
This site is not a medical provider and does not offer medical advice, diagnosis, or treatment. Information here is general and for educational purposes; decisions about medication, dose, and care should be made with a licensed clinician.
The helpline connections on this site may be answered by a sponsored treatment provider. Calls are offered as a convenience and do not represent an endorsement of any particular provider.